Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) – Analysts at Jefferies Financial Group dropped their Q2 2022 earnings per share (EPS) estimates for shares of Cogent Biosciences in a research note issued to investors on Thursday, May 12th. Jefferies Financial Group analyst E. Yang now expects that the technology company will post earnings per share […]
Zacks Investment Research upgraded shares of Cogent Biosciences (NASDAQ:COGT – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday morning, Zacks.com reports. According to Zacks, “Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company’s program consist PLX9486. […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) shares passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $6.72 and traded as high as $8.88. Cogent Biosciences shares last traded at $8.81, with a volume of 621,366 shares. Separately, Zacks Investment Research cut Cogent […]
Cogent Biosciences (NASDAQ:COGT – Get Rating) issued its quarterly earnings results on Tuesday. The technology company reported ($0.60) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.14), Fidelity Earnings reports. Shares of Cogent Biosciences stock opened at $6.18 on Friday. Cogent Biosciences has a 52-week low of $5.15 and […]